Ladera Medical Reveals Promising FASTEN Trial Outcomes for Innovative Closure System

Ladera Medical's Breakthrough in Hemostasis with FASTEN Trial Results



Ladera Medical recently announced significant findings from the FASTEN clinical trial, which evaluated their innovative Large Bore Closure System in patients who underwent transfemoral transcatheter aortic valve replacement (TAVR/TAVI). The study, comprising 55 participants across six sites in Australia, Belgium, and the Netherlands, demonstrated promising outcomes in terms of both safety and efficacy.

Study Overview


The FASTEN trial was a prospective, multicenter, single-arm study aiming to assess the performance of the Ladera Large Bore Closure System. The primary focus was on the device's capability to achieve hemostasis, alongside its associated complications at the access site. Presented by Dr. Jan van der Heyden, an interventional cardiologist, at the Late-Breaking Clinical Trials session during London Valves 2026, the results highlighted the device's effectiveness in managing large bore access closures.

Key results from this trial include:
  • - Freedom from major access-site complications at 30 days: 98.1% (52 out of 53 patients).
  • - Freedom from minor access-site complications at 30 days: 98.1% (52 out of 53 patients).
  • - Mean time to hemostasis: 0.5 ± 2.0 minutes (median: 0 minutes).
  • - Technical success rate: 94.5% (52 out of 55 patients).
  • - Treatment success rate (technical success with freedom from major complications): 94.3% (50 out of 53 patients).
  • - Mean time to ambulation post-procedure: 14.3 ± 14.5 hours.

According to Dr. van der Heyden, these impressive results indicate that Ladera's suture-based system can deliver rapid and reliable hemostasis while maintaining a low incidence of major access-site complications.

The Need for Improved Closure Methods


Transcatheter procedures are rapidly evolving and gaining popularity in the cardiovascular field, particularly TAVR/TAVI. However, closure of the femoral access site continues to pose significant challenges, contributing to complications such as bleeding and vascular injury. These issues often lead to extended procedure times and increased length of hospital stays for patients.

Dr. Robert Gooley, an interventional cardiology expert at Monash Health in Melbourne, Australia, highlighted the pressing need for reliable closure systems, especially as TAVR has become commonplace. Existing methods often involve the combination of multiple small-bore devices or leaving materials within the artery, which can lead to complications. The advent of a dedicated large bore closure system represents a welcome innovation in this space.

How the Ladera System Works


The Ladera Closure System distinguishes itself from traditional closure devices by using a suture-mediated mechanism designed specifically for large bore access sites ranging from 10F to 24F. It allows for the deployment of two sutures simultaneously, ensuring effective closure without leaving any permanent material in the artery, thus preserving the vessel for future interventions. This single device can be utilized for either pre-close or post-close approaches while maintaining access via guidewires.

This innovative approach streamlines the closure process and minimizes the risk associated with current methods.

Future Perspectives


Although the Ladera Large Bore Closure System is currently limited to investigational use per federal regulations and is not available for commercial sale, the results from the FASTEN trial shed light on its potential to significantly improve patient outcomes during TAVR/TAVI surgeries. With the medical community continuously seeking advanced solutions to minimize complications and enhance patient safety, Ladera Medical's pioneering system may well lead the way in the future of cardiovascular care.

For further information on Ladera Medical and their products, interested parties can visit their official website at laderamedical.com.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.